SearchSearch results for: “”

Advising a financial organisation how to avoid the publication of a sanction imposed by the regulator.

Stibbe advises Accor on the sale and franchise-back of 29 hotels in the Netherlands and Germany for a total value of €234 million.

Advising J.P. Morgan and the other underwriters on the notes offerings of Fiat Chrysler Automobiles N.V. for a total amount of USD 3.0 billion.

Advising an international fast moving consumer goods company on IT and privacy related matters, such as the use of cloud computing and the transfer of personal data outside of the European Economic Area.

Advising Amsterdam RAI, the largest Dutch congress and convention center, on e-commerce and privacy related matters.

Providing legal assistance to several companies with regard to investigations of the Social Affairs and Employment Inspectorate (SAE, in Dutch: Inspectie Sociale Zaken en Werkgelegenheid) and imposed fines under the Foreign Nationals (Employment) Act. 

Stibbe advises NRG Value, a Dutch fuel and convenience retail management chain recently started by former managers from Shell, Exxon Mobil and Merrill Lynch, on its acquisition of 107 Esso petrol stations from Esso Nederland, a subsidiary of Exxon Mobil.

Stibbe advised Akzo Nobel in an action before the General Court to prevent the European Commission from publishing information originating from leniency documents.

Stibbe advises J.P. Morgan and the other underwriters on the equity offering of Fiat Chrysler Automobiles N.V.

Stibbe advised Credit Suisse on the imposement of a fine by the European Commission for participating in a cartel involving interest rate products denominated in Swiss francs.

Advising the underwriters on the USD 1 billion convertible bond offering of NXP Semiconductors

Stibbe advises Tornier N.V. on its merger with Wright Medical Group, Inc. in an all stock transaction with a combined equity value of approximately $3.3 billion.

Stibbe advises Pershing Square Holdings, Ltd. on the IPO of this investment fund managed by the leading active investor Bill Ackmann.

Stibbe advises Mylan Inc., the pharmaceuticals company listed on the NASDAQ with a market cap of approximately $19 billion, on the inversion acquisition of Abbott’s non-U.S. developed markets specialty and branded generics business.